Revolutionizing cancer therapy with transport oncophysics
About Us
BrYet is a privately-owned biotech company focused on the discovery and development of novel physics-based, first-in-class therapies for metastatic liver and lung cancers.
Contact Us
BrYet US, Inc.
BrYet US, Inc.
Copyright © 2022 BrYet US, Inc. - All Rights Reserved.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.